Last edition
News about "Drugs Controller General of India "
Akums Drugs and Pharmaceuticals introduces DCGI-approved Lasmiditan dispersible tablets, offering faster, patient-friendly migraine relief with improved compliance, especially for patients facing nausea and difficulty swallowing during acute attacks.
Drugs Controller General Of India | 18/03/2026 | By News Bureau
ACC Extends Dr Rajeev Singh Raghuvanshi's appointment as Drugs Controller (India) for One Year
Dr Rajeev Singh Raghuvanshi receives a second one-year extension as head of CDSCO amid ongoing regulatory reforms and Schedule M implementation.
Drugs Controller General Of India | 02/03/2026 | By News Bureau | 332
Sun Pharma Wins DCGI Nod for Generic Semaglutide Injection
Sun Pharmaceutical has secured approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic semaglutide injection for chronic weight management, paving the way for its entry into the fast-growing obesity treatment segment once the semaglutide patent expires in the country.
Drugs Controller General Of India | 27/01/2026 | By News Bureau | 145
Health Minister Highlights Expansion of Jan Aushadhi Kendras and AMRIT Pharmacies
Union Health Minister JP Nadda underscored the importance of expanding Jan Aushadhi Kendras and AMRIT pharmacies across the country, while emphasising the need for a robust drug regulatory framework that ensures quality, safety and compliance from manufacturing through last-mile distribution.
Drugs Controller General Of India | 03/01/2026 | By News Bureau | 202
No Physical Applications For WHO-GMP (COPP) Approvals After August 15: CDSCO
The Drugs Controller General of India has directed all zonal and sub-zonal offices of the Central Drugs Standard Control Organization (CDSCO) to stop accepting physical applications for WHO-GMP (Certificate of Pharmaceutical Product – COPP) after August 15, 2025.
Drugs Controller General Of India | 08/08/2025 | By Dineshwori | 732
Akums Becomes First Indian CDMO to Receive DCGI Approval for Innovative Glaucoma Treatment
Glaucoma ranks as the second leading cause of irreversible but preventable blindness worldwide, with India contributing to 23.5 percent of the global burden.
Drugs Controller General Of India | 01/04/2025 | By Abha | 482
CDSCO Launches Digital Portal to Simplify Extension Process for Pharma MSMEs
This initiative is integrated into the Online National Drugs Licensing System (ONDLS) and follows the Health Ministry's notification granting an extension for compliance with updated Good Manufacturing Practices (GMP).
Drugs Controller General Of India | 26/03/2025 | By Aishwarya | 458
Akums Combines Two Potent Diabetes Medicines for Enhanced Treatment Efficacy
Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, aids in eliminating excess glucose via urine while delivering additional benefits such as improved cardiovascular and renal outcomes, along with better weight management.
Drugs Controller General Of India | 03/02/2025 | By Aishwarya | 647
Orchid Pharma Gets DCGI Approval for Enmetazobactam
Orchid Pharma has secured Drugs Controller General of India (DCGI) approval for the manufacturing and marketing of its invented New Chemical Entity Active Pharmaceutical Ingredient (API), Enmetazobactam.
Drugs Controller General Of India | 10/06/2024 | By Aishwarya | 726
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy